IAPs as E3 ligases of Rac1: Shaping the move

Small GTPases

Volumn 3, Issue 2, 2012, Pages 8-

  Kaur, Tripat ^a   Oberoi Khanuja, ^a   Rajalingam, Krishnaraj ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Amoeboid; Cell migration; cIAP1; E3 ligase; IAPs; Mesenchymal; Plasticity; Proteasome; Rac1; RhoA; RhoGTPases; Ubiquitin; Ubiquitination; XIAP

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; PROTEASOME; RAC1 PROTEIN; RAF PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; DEVELOPMENTAL BIOLOGY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STABILITY; METASTASIS; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR CELL; UBIQUITINATION;

INTRACISTERNAL A-PARTICLES;

EID: 84861464004     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Srinivasula SM, Ashwell JD. IAPs: what's in a name? Mol Cell 2008; 30:123-35; PMID:18439892; http://dx.doi.org/10.1016/j.molcel.2008.03.008.
2. Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NFkappaB, inflammation and cancer. Nat Rev Cancer 2010; 10:561-74; PMID:20651737; http://dx.doi.org/10.1038/nrc2889.
3. Vaux DL, Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 2005; 6:287-97; PMID:15803136; http://dx.doi.org/10.1038/nrm1621.
4. Vaux DL, Silke J. Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 2003; 304:499-504; PMID:12729584; http://dx.doi.org/10.1016/S0006-291X(03)00622-3.
5. Edison N, Zuri D, Maniv I, Bornstein B, Lev T, Gottfried Y, et al. The IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/Diablo. Cell Death Differ 2012; 19:356-68; PMID:21869827; http://dx.doi.org/10.1038/cdd.2011.112.
6. O'Riordan MX, Bauler LD, Scott FL, Duckett CS. Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation. Dev Cell 2008; 15:497-508; PMID:18854135; http://dx.doi.org/10.1016/j.devcel.2008.09.012.
7. Schile AJ, García-Fernández M, Steller H. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev 2008; 22:2256-66; PMID:18708583; http://dx.doi.org/10.1101/gad.1663108.
8. Varfolomeev E, Vucic D. (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle 2008; 7:1511-21; PMID:18469528; http://dx.doi.org/10.4161/cc.7.11.5959.
9. Reardon C, Mak TW. cIAP proteins: keystones in NOD receptor signal transduction. Immunity 2009; 30:755-6; PMID:19538923; http://dx.doi.org/10.1016/j.immuni.2009.06.005.
10. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006; 125:1253-67; PMID:16814713; http://dx.doi.org/10.1016/j.cell.2006.05.030.
11. Dogan T, Harms GS, Hekman M, Karreman C, Oberoi TK, Alnemri ES, et al. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nat Cell Biol 2008; 10:1447-55; PMID:19011619; http://dx.doi.org/10.1038/ncb1804.
12. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, et al. IAP antagonists induce autoubiquitination of c-IAPs, NFkappaB activation and TNFalpha-dependent apoptosis. Cell 2007; 131:669-81; PMID:18022362; http://dx.doi.org/10.1016/j.cell.2007.10.030.
13. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131:682-93; PMID:18022363; http://dx.doi.org/10.1016/j.cell.2007.10.037.
14. Oberoi TK, Dogan T, Hocking JC, Scholz RP, Mooz J, Anderson CL, et al. IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J 2012; 31:14-28; PMID:22117219; http://dx.doi.org/10.1038/emboj.2011.423.
15. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3:362-74; PMID:12724734; http://dx.doi.org/10.1038/nrc1075.
16. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002; 2:133-42; PMID:12635176; http://dx.doi.org/10.1038/nrc725.
17. Visvikis O, Lorès P, Boyer L, Chardin P, Lemichez E, Gacon G. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process. FEBS J 2008; 275:386-96; PMID:18093184; http://dx.doi.org/10.1111/j.1742-4658.2007.06209.x.
18. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008; 582:2093-101; PMID:18460342; http://dx.doi.org/10.1016/j.febslet.2008.04.039.
19. de la Vega M, Burrows JF, Johnston JA. Ubiquitination: Added complexity in Ras and Rho family GTPase function. Small Gtpases 2011; 2:192-201; PMID:22145091; http://dx.doi.org/10.4161/sgtp.2.4.16707.
20. Castillo-Lluva S, Tatham MH, Jones RC, Jaffray EG, Edmondson RD, Hay RT, et al. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat Cell Biol 2010; 12:1078-85; PMID:20935639; http://dx.doi.org/10.1038/ncb2112.
21. Nethe M, Hordijk PL. The role of ubiquitylation and degradation in RhoGTPase signalling. J Cell Sci 2010; 123:4011-8; PMID:21084561; http://dx.doi.org/10.1242/jcs.078360.
22. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-79; PMID:9759494; http://dx.doi.org/10.1146/annurev.biochem.67.1.425.
23. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J 2005; 24:3353-9; PMID:16148945; http://dx.doi.org/10.1038/sj.emboj.7600808.
24. Vucic D, Dixit VM, Wertz IE. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol 2011; 12:439-52; PMID:21697901; http://dx.doi.org/10.1038/nrm3143.
25. Ye Y, Rape M. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol 2009; 10:755-64; PMID:19851334; http://dx.doi.org/10.1038/nrm2780.
26. Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 2007; 31:515-34; PMID:17680807; http://dx.doi.org/10.1111/j.1574-6976.2007.00078.x.
27. Torrino S, Visvikis O, Doye A, Boyer L, Stefani C, Munro P, et al. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1. Dev Cell 2011; 21:959-65; PMID:22036506; http://dx.doi.org/10.1016/j.devcel.2011.08.015.
28. Silke J, Kratina T, Chu D, Ekert PG, Day CL, Pakusch M, et al. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci USA 2005; 102:16182-7; PMID:16263936; http://dx.doi.org/10.1073/pnas.0502828102.
29. Rajalingam K, Sharma M, Paland N, Hurwitz R, Thieck O, Oswald M, et al. IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells. PLoS Pathog 2006; 2:114; PMID:17069460; http://dx.doi.org/10.1371/journal.ppat.0020114.
30. Boulter E, Garcia-Mata R, Guilluy C, Dubash A, Rossi G, Brennwald PJ, et al. Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1. Nat Cell Biol 2010; 12:477-83; PMID:20400958; http://dx.doi.org/10.1038/ncb2049.
31. Nethe M, Anthony EC, Fernandez-Borja M, Dee R, Geerts D, Hensbergen PJ, et al. Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. J Cell Sci 2010; 123:1948-58; PMID:20460433; http://dx.doi.org/10.1242/jcs.062919.
32. Kim J, Park J, Choi S, Chi SG, Mowbray AL, Jo H, et al. X-linked inhibitor of apoptosis protein is an important regulator of vascular endothelial growth factor-dependent bovine aortic endothelial cell survival. Circ Res 2008; 102:896-904; PMID:18309102; http://dx.doi.org/10.1161/CIRCRESAHA.107.163667.
33. Sandrock K, Bielek H, Schradi K, Schmidt G, Klugbauer N. The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin alpha2. Traffic 2010; 11:198-209; PMID:19961560; http://dx.doi.org/10.1111/j.1600-0854.2009.01015.x.
34. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, Mak T, et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 2005; 25:3348-56; PMID:15798218; http://dx.doi.org/10.1128/MCB.25.8.3348-56.2005.
35. Geisbrecht ER, Montell DJ. A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration. Cell 2004; 118:111-25; PMID:15242648; http://dx.doi.org/10.1016/j.cell.2004.06.020.
36. Köster RW, Fraser SE. Direct imaging of in vivo neuronal migration in the developing cerebellum. Curr Biol 2001; 11:1858-63; PMID:11728308; http://dx.doi.org/10.1016/S0960-9822(01)00585-1.
37. Rieger S, Senghaas N, Walch A, Köster RW. Cadherin-2 controls directional chain migration of cerebellar granule neurons. PLoS Biol 2009; 7:1000240; PMID:19901980; http://dx.doi.org/10.1371/journal.pbio.1000240.
38. Mack NA, Whalley HJ, Castillo-Lluva S, Malliri A. The diverse roles of Rac signaling in tumorigenesis. Cell Cycle 2011; 10:1571-81; PMID:21478669; http://dx.doi.org/10.4161/cc.10.10.15612.
39. Lopez J, John SW, Tenev T, Rautureau GJ, Hinds MG, Francalanci F, et al. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol Cell 2011; 42:569-83; PMID:21549626; http://dx.doi.org/10.1016/j.molcel.2011.04.008.
40. Liu J, Zhang D, Luo W, Yu Y, Yu J, Li J, et al. X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J Biol Chem 2011; 286:15630-40; PMID:21402697; http://dx.doi.org/10.1074/jbc.M110.176982.
41. Hwang C, Oetjen KA, Kosoff D, Wojno KJ, Albertelli MA, Dunn RL, et al. X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model. Cell Death Differ 2008; 15:831-40; PMID:18259199; http://dx.doi.org/10.1038/cdd.2008.15.
42. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell 2010; 17:53-64; PMID:20129247; http://dx.doi.org/10.1016/j.ccr.2009.11.021.
43. Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LC, Collard JG. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 1997; 278:1464-6; PMID:9367959; http://dx.doi.org/10.1126/science.278.5342.1464.
44. Sosa MS, Lopez-Haber C, Yang C, Wang H, Lemmon MA, Busillo JM, et al. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell 2010; 40:877-92; PMID:21172654; http://dx.doi.org/10.1016/j.molcel.2010.11.029.
45. Kissil JL, Walmsley MJ, Hanlon L, Haigis KM, Bender Kim CF, Sweet-Cordero A, et al. Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Cancer Res 2007; 67:8089-94; PMID:17804720; http://dx.doi.org/10.1158/0008-5472.CAN-07-2300
46. Ong CC, Jubb AM, Haverty PM, Zhou W, Tran V, Truong T, et al. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proc Natl Acad Sci USA 2011; 108:7177-82; PMID:21482786; http://dx.doi.org/10.1073/pnas.1103350108.